Heather Smith
Advisor
Ms. Smith is an advisor to Autobahn Therapeutics and previously served as the company’s senior vice president of global clinical operations. She brings extensive global leadership and expertise across all stages of development to her role at Autobahn. She was most recently senior vice president of clinical operations and program management at Gossamer Bio where she was part of the founding leadership team. Prior to joining Gossamer Bio, Ms. Smith led clinical operations at Receptos Inc, where she was responsible for the mid- and late-stage trials for Zeposia® (ozanimod) in multiple sclerosis (MS) and inflammatory bowel diseases (IBD). She has also held leadership roles at several small biotech organizations, including Cadence Pharmaceuticals, where she managed the trials for Ofirmev® (acetaminophen injection).
Ms. Smith is a seasoned development executive who, in addition to her operational and project management leadership roles, has contributed more broadly to business development activities, the development of effective governance and the optimization of team structure and function.
Ms. Smith holds a B.A. in psychology from University of California, San Diego and an MBA with emphasis in organization management from Webster University.